These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

200 related articles for article (PubMed ID: 37305111)

  • 21. Low blood pressure and guideline-directed medical therapy in patients with heart failure with reduced ejection fraction.
    Izumi K; Kohno T; Goda A; Takeuchi S; Shiraishi Y; Saji M; Nagatomo Y; Tanaka TD; Takei M; Nakano S; Soejima K; Kohsaka S; Yoshikawa T;
    Int J Cardiol; 2023 Jan; 370():255-262. PubMed ID: 36270494
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Medication Trajectory and Treatment Patterns in Medicare Patients With Heart Failure and Reduced Ejection Fraction.
    Mentz RJ; Lautsch D; Pulungan Z; Kim S; Hilkert R; Teigland C; Yang M; Djatche L
    J Card Fail; 2022 Aug; 28(8):1349-1354. PubMed ID: 34930657
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A scoring evaluation for the practical introduction of guideline-directed medical therapy in heart failure patients.
    Matsukawa R; Okahara A; Tokutome M; Itonaga J; Koga E; Hara A; Kisanuki H; Sada M; Okabe K; Kawai S; Ogawa K; Matsuura H; Mukai Y
    ESC Heart Fail; 2023 Dec; 10(6):3352-3363. PubMed ID: 37671603
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Frailty, Guideline-Directed Medical Therapy, and Outcomes in HFrEF: From the GUIDE-IT Trial.
    Khan MS; Segar MW; Usman MS; Singh S; Greene SJ; Fonarow GC; Anker SD; Felker GM; Januzzi JL; Butler J; Pandey A
    JACC Heart Fail; 2022 Apr; 10(4):266-275. PubMed ID: 35361446
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Validation of a New Scoring Method to Assess the Efficacy of Rapid Initiation and Titration of Combination Pharmacotherapy for Patients Hospitalized with Acute Decompensated Heart Failure with Reduced and Mildly Reduced Ejection Fraction.
    Asano T; Maeno Y; Nakano M; Taguri M; Miyasaka M; Nakai D; Miyazaki I; Nasu T; Tanimoto S; Masuda N; Morino Y; Isshiki T; Ogata N
    J Clin Med; 2024 May; 13(10):. PubMed ID: 38792317
    [No Abstract]   [Full Text] [Related]  

  • 26. Effect of Optimizing Guideline-Directed Medical Therapy Before Discharge on Mortality and Heart Failure Readmission in Patients Hospitalized With Heart Failure With Reduced Ejection Fraction.
    Yamaguchi T; Kitai T; Miyamoto T; Kagiyama N; Okumura T; Kida K; Oishi S; Akiyama E; Suzuki S; Yamamoto M; Yamaguchi J; Iwai T; Hijikata S; Masuda R; Miyazaki R; Hara N; Nagata Y; Nozato T; Matsue Y
    Am J Cardiol; 2018 Apr; 121(8):969-974. PubMed ID: 29477488
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Electronic Alerts to Improve Heart Failure Therapy in Outpatient Practice: A Cluster Randomized Trial.
    Ghazi L; Yamamoto Y; Riello RJ; Coronel-Moreno C; Martin M; O'Connor KD; Simonov M; Huang J; Olufade T; McDermott J; Dhar R; Inzucchi SE; Velazquez EJ; Wilson FP; Desai NR; Ahmad T
    J Am Coll Cardiol; 2022 Jun; 79(22):2203-2213. PubMed ID: 35385798
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Assessing Guideline-Directed Medication Therapy for Heart Failure in End-Stage Renal Disease.
    Cutshall BT; Duhart BT; Saikumar J; Samarin M; Hutchison L; Hudson JQ
    Am J Med Sci; 2018 Mar; 355(3):247-251. PubMed ID: 29549927
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Background pharmacological therapy in the ANTHEM-HF: comparison to contemporary trials of novel heart failure therapies.
    Premchand RK; Sharma K; Mittal S; Monteiro R; Libbus I; Ardell JL; Gregory DD; KenKnight BH; Amurthur B; DiCarlo LA; Anand IS
    ESC Heart Fail; 2019 Oct; 6(5):1052-1056. PubMed ID: 31339232
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Five-year mortality and readmission rates in patients with heart failure in India: Results from the Trivandrum heart failure registry.
    Harikrishnan S; Jeemon P; Ganapathi S; Agarwal A; Viswanathan S; Sreedharan M; Vijayaraghavan G; Bahuleyan CG; Biju R; Nair T; Pratapkumar N; Krishnakumar K; Rajalekshmi N; Suresh K; Huffman MD
    Int J Cardiol; 2021 Mar; 326():139-143. PubMed ID: 33049297
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Evaluating Guideline Directed Medical Therapy in Patients With Heart Failure With Reduced Ejection Fraction Post-coronary Artery Bypass Grafting.
    Kabulski GM; Boughner T; Szymanski TW; Sokos GG; Kido K
    J Pharm Pract; 2023 Dec; 36(6):1370-1374. PubMed ID: 35926866
    [No Abstract]   [Full Text] [Related]  

  • 32. Medication and Outcome in Older Heart Failure Patients: Results from a Prospective Cohort Study.
    Garay DP; Saner H; Herzberg J; Hellige G; Arenja N
    Pharmaceuticals (Basel); 2024 May; 17(6):. PubMed ID: 38931378
    [No Abstract]   [Full Text] [Related]  

  • 33. Use of heart failure medical therapy before and after a cancer diagnosis: A longitudinal study.
    Ju C; Lau WCY; Manisty C; Chambers P; Brauer R; Forster MD; Mackenzie IS; Wei L
    ESC Heart Fail; 2024 Jul; ():. PubMed ID: 39041459
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
    Sharma A; Verma S; Bhatt DL; Connelly KA; Swiggum E; Vaduganathan M; Zieroth S; Butler J
    JACC Basic Transl Sci; 2022 May; 7(5):504-517. PubMed ID: 35663626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Evaluation of Guideline-Directed Medical Therapy for Outpatients Living with Heart Failure with Reduced Ejection Fraction.
    McVannel T; Albers L; Kosar L; Reid B; Yeung C; Siddiqui M; Baran O
    Can J Hosp Pharm; 2024; 77(1):e3373. PubMed ID: 38482388
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Optimization of Evidence-Based Heart Failure Medications After an Acute Heart Failure Admission: A Secondary Analysis of the STRONG-HF Randomized Clinical Trial.
    Cotter G; Deniau B; Davison B; Edwards C; Adamo M; Arrigo M; Barros M; Biegus J; Celutkiene J; Cerlinskaite-Bajore K; Chioncel O; Cohen-Solal A; Damasceno A; Diaz R; Filippatos G; Gayat E; Kimmoun A; Lam CSP; Metra M; Novosadova M; Pang PS; Pagnesi M; Ponikowski P; Saidu H; Sliwa K; Takagi K; Ter Maaten JM; Tomasoni D; Voors A; Mebazaa A
    JAMA Cardiol; 2024 Feb; 9(2):114-124. PubMed ID: 38150260
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polypharmacy and Optimization of Guideline-Directed Medical Therapy in Heart Failure: The GUIDE-IT Trial.
    Khan MS; Singh S; Segar MW; Usman MS; Keshvani N; Ambrosy AP; Fiuzat M; Van Spall HGC; Fonarow GC; Zannad F; Felker GM; Januzzi JL; O'Connor C; Butler J; Pandey A
    JACC Heart Fail; 2023 Nov; 11(11):1507-1517. PubMed ID: 37115133
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The independent reduction in mortality associated with guideline-directed medical therapy in patients with coronary artery disease and heart failure with reduced ejection fraction.
    Wolfe NK; Mitchell JD; Brown DL
    Eur Heart J Qual Care Clin Outcomes; 2021 Jul; 7(4):416-421. PubMed ID: 32324852
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Optimal Heart Failure Medical Therapy and Mortality in Survivors of Cardiogenic Shock: Insights From the FRENSHOCK Registry.
    Matsushita K; Delmas C; Marchandot B; Roubille F; Lamblin N; Leurent G; Levy B; Elbaz M; Champion S; Lim P; Schneider F; Khachab H; Carmona A; Trimaille A; Bourenne J; Seronde MF; Schurtz G; Harbaoui B; Vanzetto G; Biendel C; Labbe V; Combaret N; Mansourati J; Filippi E; Maizel J; Merdji H; Lattuca B; Gerbaud E; Bonnefoy E; Puymirat E; Bonello L; Morel O
    J Am Heart Assoc; 2024 Mar; 13(5):e030975. PubMed ID: 38390813
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Guideline-directed medical therapy in heart failure patients with reduced ejection fraction in Palestine: Retrospective clinical audit study.
    Jairoun AA; Al-Hemyari SS; Shahwan M; Zyoud SH; Jairoun M
    Saudi Pharm J; 2024 Mar; 32(3):101965. PubMed ID: 38313821
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.